Dr David J. Kerr reviews HDAC and immune checkpoint inhibitors, therapies on the horizon for a subset of patients with colorectal cancers.

Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play.

Dr Paul Auwaerter addresses some misunderstandings about the management of Clostridium difficile infection that he discovered during his time on a consultation service.

Dr David Kerr views a case of engineered T cells in a CRC patient with pulmonary metastases as an example of a single-patient clinical trial, neatly illustrating the potential of precision medicine.

Tumor location, whether on the right or left side of the colon, seems to affect the prognosis and aggressiveness of recurrent colorectal cancer.

IBD puts patients at risk for a variety of non-GI disorders and requires their doctors to provide comprehensive care. Dr David Johnson reviews new guidelines that make this task easier.

In the third installment of this series on managing obesity in primary care, Drs Vega and Apovian discuss the surgical approach.

In the years after surgery, micro- and macronutrient impairments present a significant risk. Dr David Johnson tells you how to identify signs of trouble.

In this quick summary, Dr Bhargava reviews the many diet trends that swirl around on websites, blogs, and discussion boards. What do you need to know?

Dr David Johnson reviews the optimal diagnostic and treatment strategies for ischemic colitis, particularly isolated right-sided colon ischemia, a disease not to be missed.